Daxor Valuation Analysis

Stocks . USA . 
Stock . Daxor
DXR Stock  USD 9.66  -0.48  -4.73%   
Daxor trades at a discounted earnings multiple relative to broader benchmarks, shaped by strong margins and conservative leverage. Daxor's enterprise value is currently 42.9 M. The trailing price-to-earnings ratio currently stands at 10.77.
Above Model Estimate
Today
9.66
The intrinsic value estimate for Daxor is based on a 3 months horizon. Extending the time horizon generally improves valuation stability.
4.91
Downside
7.82
Intrinsic Value
10.73
Upside
Current intrinsic value estimate framed by downside and upside probability thresholds.
Target Odds

Valuation Framework, Methodology & Assumptions

Daxor is a micro-cap equity. Valuation integrates earnings durability and capital efficiency. Certain defensive traits may reduce sensitivity to broader macroeconomic fluctuations. On a relative-multiples basis, Daxor is priced at P/S of 2279.54, enterprise value (TTM) of 42.93 million, P/E of 10.77.

Daxor analytics rely on periodic company reporting and market reference feeds, with quality checks and normalization applied. Valuation outputs are model-derived and depend on published assumptions and reference inputs.

The analysis above is generated by quantitative models and is provided for informational and educational purposes only. It does not constitute financial advice, investment recommendations, or an endorsement to buy or sell any security. All investing involves risk, including the possible loss of principal. Consult a qualified financial advisor before making investment decisions. See our Terms of Use for full details.

Financial data referenced in this analysis is derived from publicly available SEC filings, audited financial statements, and third-party market data providers. The intrinsic value estimate is generated by Macroaxis quantitative models that incorporate fundamental analysis, technical indicators, and risk metrics.

The methodology combines multiple analytical inputs:

  • Fundamental analysis - financial statements, profitability ratios, debt structure, and cash flow metrics sourced from SEC filings and public financial reports
  • Technical indicators - historical price patterns, momentum signals, and volatility measures
  • Risk assessment - probability of bankruptcy models, market risk metrics, and downside scenario analysis
  • Peer comparison - relative valuation against industry peers using standardized multiples

Model outputs are refreshed periodically as new financial data becomes available. Past model performance is not indicative of future results. The intrinsic value estimate reflects a point-in-time calculation and should be considered alongside other research and professional advice.

Data sourced from SEC filings (EDGAR), public financial statements, and market data providers.

Editorial review and methodology oversight provided by: Gabriel Shpitalnik, Member of Macroaxis Editorial Board

Growth Indicators

A growth framework around Daxor should test whether the business is actually regaining operating strength instead of assuming the market is pricing in a classic high-growth trajectory. In this context, the key question is whether current momentum can rebuild durable earnings power rather than simply produce a short-lived rebound.
Common Stock Shares Outstanding4.99 million
Quarterly Earnings Growth Y O Y329.3%
Forward Price Earnings64.5161
Shares Float2.57 million

Additional Tools for Daxor Stock Analysis

Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.